Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1995 | 03-1995 | 12-1994 | 09-1994 | 06-1994 | |
| Sales | 12,570 | 6,000 | 9,200 | 13,140 | 2,550 |
| Cost of Goods | 10,270 | 5,760 | 12,940 | 10,560 | 2,610 |
| Gross Profit | 2,300 | 240 | -3,740 | 2,580 | -60 |
| Operating Expenses | 0 | 0 | 340 | 0 | 0 |
| Operating Income | 2,300 | 240 | -4,080 | 2,580 | -60 |
| Interest Expense | 8 | 3 | -56 | 6 | 30 |
| Other Income | -1,872 | -1,887 | 4,855 | -1,415 | -1,320 |
| Pre-tax Income | 420 | -1,650 | 830 | 1,160 | -1,410 |
| Income Tax | 0 | 0 | 310 | 0 | 0 |
| Net Income Continuous | 420 | -1,650 | 520 | 1,160 | -1,410 |
| Net Income | $250 | $-990 | $440 | $690 | $-840 |
| EBITDA(a) | $2,300 | $240 | $-4,080 | $2,580 | $-60 |